Pregabalin Prescribing in Arizona: 90-Day Supply and Refills
In Arizona, you can obtain a 90-day supply of pregabalin with refills, as pregabalin is classified as a Schedule V controlled substance under federal law, which permits refills up to 5 times within 6 months from the date of issue.
Regulatory Classification
Pregabalin is designated as a Schedule V controlled substance in the United States 1. This is the least restrictive controlled substance category and carries significantly different prescribing rules compared to Schedule II-IV medications.
Supply Duration
A 90-day supply is permissible. There are no federal or Arizona-specific restrictions limiting pregabalin prescriptions to shorter durations like 30 days. The prescriber can write for any clinically appropriate quantity, including:
- 30-day supply
- 60-day supply
- 90-day supply
- Or any other duration deemed medically necessary
The 90-day supply option is particularly practical for stable patients on maintenance therapy for conditions like neuropathic pain, where pregabalin demonstrates sustained efficacy 2.
Refill Allowances
Schedule V medications allow up to 5 refills within 6 months from the original prescription date. This means:
- The original prescription can be written with authorization for up to 5 refills
- All refills must be dispensed within 6 months of the prescription date
- After 6 months or 5 refills (whichever comes first), a new prescription is required
This is substantially more flexible than Schedule II opioids, which cannot have refills at all, or Schedule III-IV substances, which also have refill limitations.
Clinical Context
Pregabalin is FDA-approved for neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia 2. The typical therapeutic dosing ranges from 150-600 mg/day in divided doses 1. When prescribing for chronic conditions requiring long-term therapy, the ability to provide 90-day supplies with refills improves medication adherence and reduces administrative burden for both patients and healthcare systems.
Important Caveats
While 90-day supplies with refills are legally permissible, prescribers should:
- Monitor for abuse potential: Although pregabalin is Schedule V, studies show 8.5-9.6% of users may receive doses exceeding the maximum recommended 600 mg/day 3, 4, with higher risk in patients with substance use history
- Adjust for renal function: Pregabalin is renally cleared and requires dose reduction in patients with creatinine clearance <60 mL/min 1, 2
- Consider patient-specific factors: Male gender, younger age (18-29 years), history of substance use disorder, and concurrent benzodiazepine or antipsychotic use are associated with higher-dose prescribing 4
The Schedule V classification reflects pregabalin's lower abuse potential compared to traditional opioids, making extended supplies with refills both legally compliant and clinically appropriate for stable patients.